会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 74. 发明授权
    • L-lyxohex-1-enopyranose derivative
    • L-赖索昔-1-吡喃葡萄糖衍生物
    • US4020270A
    • 1977-04-26
    • US650519
    • 1976-01-19
    • Federico ArcamoneGiuseppe Cassinelli
    • Federico ArcamoneGiuseppe Cassinelli
    • C07D309/30C07H15/252C07H5/06
    • C07H15/252C07D309/30Y02P20/55
    • Anthracyclinone glycoside antibiotics including the known antibiotics daunomycin and adriamycin, as well as other, novel glycoside antibiotics of the formula (VIII): ##STR1## wherein WHEN R.sub.1 is hydrogen, R.sub.2 and R.sub.3 are each independently hydrogen, methyl, methoxy, chloro, or bromo; and when R.sub.2 and R.sub.3 are hydrogen, R.sub.1 is methyl, chloro, or bromo and R.sub.4 and R.sub.5 are each independently hydrogen or hydroxy are prepared by an acid catalyzed addition reaction between (a) an anthracyclinone compound of the formula ##STR2## or a dioxolanyl protected derivative thereof (VI) having the formula: ##STR3## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as defined above, and R.sub.6, R.sub.7 and R.sub.8 are independently selected from the group consisting of hydrogen and C.sub.1 -C.sub.4 alkyl; or R.sub.7 and R.sub.8, together with the carbon atom to which they are bound may form a saturated or unsaturated ring of 3-8 carbon atoms and (b) a novel reactive, protected 1,2-unsaturated pyranoid sugar, preferably, 1,2,3,6-tetradeoxy-3-trifluoroacetamido-4-trifluoroacetoxy-L-lyxo-hex-1-enopyranose which forms protected derivatives of said glycoside antibiotics and then removing the protecting groups from said glycoside antibiotics. These antibiotics are useful in the treatment of various human cancers and leukemia such as sarcomas, breast cancer, bronchogenic carcinoma, malignant lymphomas, neuroblastomas, acute leukemia and bladder cancer.
    • 蒽环类抗生素包括已知的抗生素道诺霉素和阿霉素,以及其它式(VIII)的新型糖苷抗生素:其中当R1是氢时,R2和R3各自独立地是氢,甲基,甲氧基, 氯或溴; 并且当R 2和R 3为氢时,R 1为甲基,氯或溴,并且R 4和R 5各自独立地为氢或羟基,是通过(a)式(III)的蒽环类化合物之间的酸催化加成反应制备的, 或其具有下式的二氧杂环戊烷基保护的衍生物(VI):其中R 1,R 2,R 3,R 4和R 5如上所定义,并且R 6,R 7和R 8独立地选自氢 和C 1 -C 4烷基; 或R 7和R 8与它们所连接的碳原子一起可以形成3-8个碳原子的饱和或不饱和的环,和(b)新的反应性保护的1,2-不饱和吡喃糖,优选1,2 ,3,6-四脱氧-3-三氟乙酰氨基-4-三氟乙酰氧基-L-赖摩尔 - 己-1-吡喃糖,其形成所述糖苷抗生素的受保护的衍生物,然后从所述糖苷抗生素中除去保护基团。 这些抗生素可用于治疗各种人类癌症和白血病如肉瘤,乳腺癌,支气管癌,恶性淋巴瘤,神经母细胞瘤,急性白血病和膀胱癌。
    • 78. 发明授权
    • .beta.-Lactam-containing antibacterial agents and .beta.-lactamase
inhibitors
    • 含β-内酰胺的抗菌剂和β-内酰胺酶抑制剂
    • US4558042A
    • 1985-12-10
    • US595336
    • 1984-03-30
    • Maurizio FoglioGiovanni FranceschiCosimo ScarafileFederico ArcamoneAurora Sanfilippo
    • Maurizio FoglioGiovanni FranceschiCosimo ScarafileFederico ArcamoneAurora Sanfilippo
    • C07D499/88C07D499/00A61K31/425
    • C07D499/88
    • There are disclosed .beta.-lactam-containing compounds of the formula: ##STR1## where R is hydrogen, lower alkyl, trichloroethyl, acetonyl, benzyl, substituted benzyl, phenyl, substituted phenyl, benzidryl or a residue that will undergo metabolic activation "in vivo" and have favorable pharmacokinetic properties; R.sup.1 is a hydrogen atom, lower alkyl, lower alkoxy, cycloalkyl, or hydroxyalkyl, with the alcoholic function of the hydroxyalkyl being free or protected; Z is hydrogen, halogen, hydroxy, amino, carbamoyloxy, mercapto, pyridinium, OR.sup.2, OCOR.sup.2, NHCOR.sup.2, or SR.sup.3 wherein each of R.sup.2 and R.sup.3 is any of lower alkyl, aryl, or a heterocyclic ring, each of which may be substituted or unsubstituted, and n is 0 or 1. The compounds have broad spectrum antibacterial activity and .beta.-lactamase inhibiting activity. Processes for the production of the .beta.-lactam-containing compounds and various intermediates in the production of those compounds are also disclosed.
    • 公开了含有β-内酰胺的化合物,其中R为氢,低级烷基,三氯乙基,丙酰基,苄基,取代的苄基,苯基,取代的苯基,苯并或将经历代谢活化的残基。 “并具有有利的药代动力学性质; R1是氢原子,低级烷基,低级烷氧基,环烷基或羟基烷基,其羟基烷基的醇官能团是游离或保护的; Z是氢,卤素,羟基,氨基,氨基甲酰氧基,巯基,吡啶鎓,OR2,OCOR2,NHCOR2或SR3,其中R2和R3各自为低级烷基,芳基或杂环, 未取代的,n为0或1.该化合物具有广谱抗菌活性和β-内酰胺酶抑制活性。 还公开了用于生产含有β-内酰胺的化合物和这些化合物生产中的各种中间体的方法。
    • 79. 发明授权
    • Paromomycin containing compounds and method of use
    • 含有溴霉素的化合物及其使用方法
    • US4337248A
    • 1982-06-29
    • US156478
    • 1980-06-04
    • Carlo BattistiniGiuseppe CassinelliGiovanni FranceschiRosanna MazzoleniFederico Arcamone
    • Carlo BattistiniGiuseppe CassinelliGiovanni FranceschiRosanna MazzoleniFederico Arcamone
    • C07H5/06A61K31/70A61K31/702A61K31/7028A61K31/7034A61K31/7036A61P31/04C07H15/232A61K31/71C07H15/22
    • C07H15/232
    • Compounds are disclosed of the formula ##STR1## wherein R.sub.1 represents a hydrogen or chlorine atom, as well as intermediates. These include 4'-deoxy-paromomycin; 4'-deoxy-4'-epi-chloro-paromomycin; 4'-deoxy-4'-epi-chloro-penta-N-benzyloxycarbonylparomomycin; 4'-deoxy-penta-N-benzyloxycarbonylparomomycin; 6,3',2",5",3"',4"'-hexa-O-acetyl-6'-O-benzoyl-4'-deoxy-penta-N-benzyloxycarbonylparomomycin; 6,3',2",5",3"',4"'-hexa-O-acetyl-6'-O-benzoyl-4'-epi-chloro-4'-deoxy-penta-N-benzyloxycarbonylparomomycin; 6,3',2",5",3"',4"'-hexa-O-acetyl-6'-O-benzyl-penta-N-benzyloxycarbonylparomomycin; 6,3',2",5",3"',4"'-hexa-O-acetyl-6'-O-benzoyl-4'-O-[(methylthio)-thiocarbonyl]-penta-N-benzyloxycarbonylparomomycin; and 6,3',2",5",3"',4"'-hexa-O-acetyl-6'-O-benzoyl-4'-O-[(phenylthio)-thiocarbonyl]-penta-N-benzyloxycarbonylparomomycin. The compounds illustrated by the structural formula are useful in treating amoebic dysentery in man and animals.
    • 公开了下式的化合物:其中R 1表示氢或氯原子,以及中间体。 这些包括4'-脱氧巴马霉素; 4'-脱氧-4'-表 - 氯 - 巴龙霉素; 4'-脱氧-4'-表 - 氯 - 五-N-苄氧羰基巴霉素; 4'-脱氧 - 五-N-苄氧羰基巴霉素; 6,3',2“,5”,3“,4”' - 六-O-乙酰基-6'-O-苯甲酰基-4'-脱氧-5-N-苄氧基羰基巴霉素; 6,3',2“,5”,3“,4” - 六-O-乙酰基-6'-O-苯甲酰基-4'-表氯 - 4'-脱甲基 - 五 -N-苄氧羰基巴霉素; 6,3',2“,5”,3“,4”' - 六-O-乙酰基-6'-O-苄基 - 五-N-苄氧基氨基辛基巴霉素; 6,3',2“,5”,3“,4” - 六-O-乙酰基-6'-O-苯甲酰基-4'-O - [(甲硫基) - 噻吩基] 五-N-苄氧羰基巴霉素; 和6,3',2“,5”,3“,4” - 六-O-乙酰基-6'-O-苯甲酰基-4'-O - [(苯硫基) - 噻吩基] - 五-N-苄氧羰基巴霉素。 由结构式表示的化合物可用于治疗人和动物中的阿米巴痢疾。